Global Pharmaceuticals Excipients Market Research Report 2021

Pharmaceutical Excipients Excipients are crucial to drug delivery within the body. Generally, an excipient has no medicinal properties. Its standard purpose is to streamline the manufacture of the drug product and ultimately facilitate physiological absorption of the drug. Excipients might aid in lubricity, flowability, disintegration, taste and may confer some form of antimicrobial function. Selecting the appropriate excipient to support the design of your pharmaceutical formulation is an important step in the drug manufacturing process.
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use.

The global Pharmaceuticals Excipients market was valued at US$ 6104.8 million in 2020 and is expected to reach US$ 8136 million by the end of 2027, growing at a CAGR of 3.7% during 2021-2027.
This report focuses on Pharmaceuticals Excipients volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pharmaceuticals Excipients market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Pharmaceuticals Excipients Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Binder
Glidents
Diluents
Disintegrants
Other

Segment by Application
Oral
Topical
Parenteral
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
DowDuPont
ER-KANG
JRS Pharma
BASF
Lubrizol
Ashland
Roquette
Shin-Etsu
Evonik
Associated British Foods
Anhui Sunhere Pharmaceutical
CHASE SUN
Shenzhou Yiqiao
EHUA